MolNFT v1 · #78586 · protein
Ethionamide boosters part 2: combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole ethr inhibitors.
3SDG: “Ethionamide boosters part 2: combining bioisosteric replacement and structure-based drug design to solve…”. X-ray diffraction. MolNFT v1 #78586 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3SDG
- Type
- protein
- Length
- 184 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P96222
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 184 | — | P96222 |
Compared structures
- 3SDG · Ethionamide Boosters Part 2: Combining Bioisosteric Replacement and Structure-Based Drug… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P96222
- Elsewhere: RCSB PDB 3SDG · PDBe 3SDG · UniProt P96222
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.